Orthopedic Regenerative Medicine Market Is Growing Rapidly With Eli Lily And Company Acquiring Prevail Therapeutics Including Clinical Program PR001, An Experimental Gene-Therapy For Neuronopathic Gaucher Disease
Orthopedic regenerative medicine is a rapidly expanding area of medical science. As medical science continues to discover new and effective ways to deliver treatments to patients, it is often changing the way we do surgery. For example, researchers have learned that by using stem cells in anti-inflammatory arthritis clinical trials, the pain experienced by some patients can be greatly reduced. Stem cells are also being used for the direct delivery of anti-inflammatory proteins in cartilage repair and tissue regeneration. These types of treatments hold great promise for treating a wide variety of ailments. Rising prevalence of chronic diseases such as osteoarthritis and tendon, ligament, and cartilage injuries is expected to drive growth of the global orthopedic regenerative medicine market. According to the Centers for Disease Control and Prevention (CDC), osteoarthritis affects over 32.5 million U.S. adults. According to the global burden of disease study, around 10 to 15% of ...